GATA6 and gastric cancer: To disclose the metabolic behaviors between trastuzumab resistant gastric cancer cells with GATA6 knockout and trastuzumab resistant cells, an untargeted metabolomics-based strategy was applied to profile the metabolites in ESI+ and ESI-, respectively.